Camonsertib
In Stock•Starting at $161 for 1 mg•Purity ≥ 99%
| CAS No. | 2417489-10-0 |
|---|---|
| MDL No. | N/A |
| MF | C21H26N6O3 |
| MW | 410.50 |
| InChI Key | YIHHYCIYAIVQKX-YNOVCBQDSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $161 | In Stock | |
| 5 mg | 99% | $397 | In Stock | |
| 10 mg | 99% | $597 | In Stock | |
| 25 mg | 99% | $1191 | In Stock | |
| 50 mg | 99% | $1665 | In Stock |
Product Information
Camonsertib is a pyrazolopyridine containing a 1H-pyrazolo[3,4-b]pyridine core substituted with 1H-pyrazol-3-yl, (3-endo)-3-hydroxy-8-oxabicyclo[3.2.1]octan-3-yl, and (3R)-3-methylmorpholin-4-yl groups at positions 1, 4, and 6, respectively. It is a highly potent and selective ATR kinase inhibitor (IC50 = 1 nM) with antineoplastic activity. It functions as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor and belongs to morpholines, imidazoles, tertiary alcohols, oxabicycloalkanes, and pyrazolopyridines.
| CAS No. | 2417489-10-0 |
|---|---|
| Product Name | Camonsertib |
Associated Conditions
neoplasm·non-small cell lung carcinoma
* The information provided here is compiled from public sources and is for reference only.